Scarica l'app Stockscreener
2.925
6.55%
-0.215
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MRVI Giù?
Forum
Previsione
Precedente Chiudi:
$3.14
Aprire:
$3.14
Volume 24 ore:
1.15M
Relative Volume:
0.80
Capitalizzazione di mercato:
$423.18M
Reddito:
$288.95M
Utile/perdita netta:
$-119.03M
Rapporto P/E:
-3.2482
EPS:
-0.9005
Flusso di cassa netto:
$60.67M
1 W Prestazione:
-12.14%
1M Prestazione:
-5.04%
6M Prestazione:
+41.76%
1 anno Prestazione:
-60.66%
Intervallo 1D:
$2.91
$3.17
Intervallo di 1 settimana:
$2.925
$3.40
Portata 52W:
$1.665
$8.29
Maravai Lifesciences Holdings Inc Stock (MRVI) Company Profile
Nome
Maravai Lifesciences Holdings Inc
Settore
Industria
Telefono
(858) 546-0004
Indirizzo
10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO
Confronta MRVI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MRVI
Maravai Lifesciences Holdings Inc
|
2.925 | 454.29M | 288.95M | -119.03M | 60.67M | -0.9005 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.18 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.37 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
433.51 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
825.40 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.32 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Maravai Lifesciences Holdings Inc Stock (MRVI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-26 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-12-19 | Iniziato | Guggenheim | Neutral |
| 2024-12-05 | Downgrade | Goldman | Neutral → Sell |
| 2024-11-14 | Iniziato | Wolfe Research | Peer Perform |
| 2024-11-08 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-08-13 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-04-10 | Iniziato | Craig Hallum | Buy |
| 2023-12-12 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2023-08-08 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-23 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2023-05-09 | Downgrade | Goldman | Buy → Neutral |
| 2023-01-05 | Downgrade | UBS | Buy → Neutral |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-11-03 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2020-12-16 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-12-15 | Iniziato | BofA Securities | Buy |
| 2020-12-15 | Iniziato | Credit Suisse | Outperform |
| 2020-12-15 | Iniziato | Goldman | Buy |
| 2020-12-15 | Iniziato | Jefferies | Buy |
| 2020-12-15 | Iniziato | Robert W. Baird | Outperform |
| 2020-12-15 | Iniziato | Stifel | Buy |
| 2020-12-15 | Iniziato | William Blair | Outperform |
| 2020-12-14 | Iniziato | UBS | Buy |
Mostra tutto
Maravai Lifesciences Holdings Inc Borsa (MRVI) Ultime notizie
Is Maravai LifeSciences Holdings Inc. stock a bargain at current levels2025 Winners & Losers & Safe Entry Momentum Tips - newser.com
Identifying reversal signals in Maravai LifeSciences Holdings Inc.July 2025 Outlook & Stepwise Trade Signal Implementation - newser.com
Will Maravai LifeSciences Holdings Inc. (MAR) stock benefit from infrastructure billJuly 2025 Market Mood & High Yield Equity Trading Tips - newser.com
Is Maravai LifeSciences Holdings Inc. stock ready for a breakoutQuarterly Portfolio Review & Long-Term Safe Investment Plans - newser.com
Will Maravai LifeSciences Holdings Inc. (MAR) stock enhance shareholder valueGDP Growth & Consistent Profit Trade Alerts - newser.com
Why Maravai LifeSciences Holdings Inc. (MAR) stock appeals to dividend investors2025 Bull vs Bear & Stock Portfolio Risk Control - newser.com
Will Maravai LifeSciences Holdings Inc. stock reach all time highs in 2025 - newser.com
Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Will Maravai LifeSciences Holdings Inc. (MAR) stock beat growth indexesQuarterly Trade Review & Reliable Breakout Forecasts - newser.com
Will Maravai LifeSciences Holdings Inc. stock gain from lower inflationWeekly Trade Analysis & Accurate Technical Buy Alerts - newser.com
Maravai LifeSciences Holdings, Inc. (MRVI) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Maravai LifeSciences Holdings, Inc. (MRVI) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Will Maravai LifeSciences Holdings Inc. stock outperform tech sector in 2025July 2025 Macro Moves & Low Risk Entry Point Guides - newser.com
How moving averages guide Maravai LifeSciences Holdings Inc. tradingJuly 2025 Catalysts & Reliable Momentum Entry Alerts - newser.com
Maravai Lifesciences stock hits 52-week low at $4.19 - MSN
How supply shortages influence Maravai LifeSciences Holdings Inc. (MAR) stockEarnings Overview Report & Expert Verified Movement Alerts - newser.com
Why Maravai LifeSciences Holdings Inc. stock remains resilient2025 Trading Recap & Precise Trade Entry Recommendations - newser.com
Maravai LifeSciences Sees Unusually Large Options Volume (NASDAQ:MRVI) - MarketBeat
How Maravai LifeSciences Holdings Inc. stock benefits from strong dollar2025 Geopolitical Influence & Low Risk Entry Point Tips - newser.com
What technical signals suggest for Maravai LifeSciences Holdings Inc. stock2025 Volatility Report & Verified Entry Point Detection - newser.com
Is Maravai LifeSciences Holdings Inc. stock supported by strong cash flowsJuly 2025 Setups & High Yield Equity Trading Tips - newser.com
Using Ichimoku Cloud for Maravai LifeSciences Holdings Inc. technicals2025 Bull vs Bear & Reliable Price Breakout Signals - newser.com
Net current asset value per share of Maravai Lifesciences Holdings, Inc. Class A – DUS:MAR - TradingView
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Wolfe Research Initiates Coverage of Maravai LifeSciences Holdings (MRVI) with Peer Perform Recommendation - MSN
Maravai LifeSciences (MRVI) to Release Quarterly Earnings on Thursday - MarketBeat
Is Polysil Irrigation Systems Limited Stock Risky in the Current Market EnvironmentReal Estate Investment Trusts & Market Monitoring and Alerts - earlytimes.in
MARAVAI INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. - GlobeNewswire
First Pacific Advisors LP Buys Shares of 741,332 Maravai LifeSciences Holdings, Inc. $MRVI - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Can Maravai LifeSciences Holdings Inc. stock beat analyst upgradesJuly 2025 Trade Ideas & High Accuracy Swing Entry Alerts - fcp.pa.gov.br
Maravai Lifesciences Holdings Inc Azioni (MRVI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.29%
0.16%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):